Free Trial
→ Buffett’s Next Move Could Shock Wall Street (From Golden Portfolio) (Ad)
NASDAQ:GCTK

GlucoTrack 5/15/2024 Earnings Report

GlucoTrack logo
$0.13 0.00 (-2.69%)
As of 12:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
ProfileEarnings History

GlucoTrack EPS Results

Actual EPS
-$12.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Date
5/15/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GlucoTrack Earnings Headlines

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28 at 8:30 AM | globenewswire.com
GCTK stock plunges to 52-week low, touches $0.13
May 23, 2025 | uk.investing.com
Buffett’s Next Move Could Shock Wall Street
In just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next great gold rush. Savvy insiders are quietly positioning now… before Buffett makes it official. Garrett Goggin has already pinpointed four tiny-gold-miners that could 100X once the announcement hits. It’s the perfect moment to be greedy — before the herd wakes up.
May 30, 2025 | Golden Portfolio (Ad)
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
May 20, 2025 | globenewswire.com
GlucoTrack, Inc.: Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 15, 2025 | finanznachrichten.de
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 14, 2025 | globenewswire.com
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles